Background: A substantial proportion of patients with ST-segment elevation myocardial infarction (STEMI) do not receive reperfusion therapy.The aim of our study was to investigate the relative benefits of enoxaparine compared to unfractioned heparin (UFH) in association with clopidogrel in STEMI patients not undergoing reperfusion therapy. Methods: We enrolled 1440 consecutive patients with STEMI from 2007 to 2011. A total of 584 patients (40.6 %) did not receive reperfusion therapy. At admission, 223 were treated with enoxaparine and 292 patients with UFH. All patients received aspirin and/or clopidogrel. No significant differences were found in the concomitant medications between the group treated with enoxaparine compared to UFH treated ...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
CONTEXT: Enoxaparin or the combination of glycoprotein IIb/IIIa inhibitor tirofiban with unfractiona...
ObjectivesWe sought to evaluate whether enoxaparin (ENOX) is superior to unfractionated heparin (UFH...
Background: A substantial proportion of patients with ST-segment elevation myocardial infarction (ST...
Objective: We sought explore the relative benefits of unfractionated heparin (UFH) compared with eno...
Objective: We sought explore the relative benefits of unfractionated heparin (UFH) compared with en...
ObjectivesThe purpose of this study was to determine the efficacy and safety of enoxaparin (ENOX) ve...
Background: Most patients with acute myocardial infarction with ST-segment elevation (STEMI) are sti...
AbstractObjectivesThis study was designed to assess whether use of enoxaparin during percutaneous co...
Background: Unfractionated heparin (UFH), despite its limitations, has been used as the primary anti...
AbstractObjectivesThe aims of the Safety and Efficacy of Subcutaneous Enoxaparin Versus Intravenous ...
AIMS: To evaluate clinical outcomes associated with the combined use of clopidogrel and statins vs. ...
OBJECTIVES: The purpose of this study is to evaluate hospital mortality and major bleeding rates amo...
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
textIntroduction: Proton pump inhibitors (PPI) may impair the biotransformation of clopidogrel leadi...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
CONTEXT: Enoxaparin or the combination of glycoprotein IIb/IIIa inhibitor tirofiban with unfractiona...
ObjectivesWe sought to evaluate whether enoxaparin (ENOX) is superior to unfractionated heparin (UFH...
Background: A substantial proportion of patients with ST-segment elevation myocardial infarction (ST...
Objective: We sought explore the relative benefits of unfractionated heparin (UFH) compared with eno...
Objective: We sought explore the relative benefits of unfractionated heparin (UFH) compared with en...
ObjectivesThe purpose of this study was to determine the efficacy and safety of enoxaparin (ENOX) ve...
Background: Most patients with acute myocardial infarction with ST-segment elevation (STEMI) are sti...
AbstractObjectivesThis study was designed to assess whether use of enoxaparin during percutaneous co...
Background: Unfractionated heparin (UFH), despite its limitations, has been used as the primary anti...
AbstractObjectivesThe aims of the Safety and Efficacy of Subcutaneous Enoxaparin Versus Intravenous ...
AIMS: To evaluate clinical outcomes associated with the combined use of clopidogrel and statins vs. ...
OBJECTIVES: The purpose of this study is to evaluate hospital mortality and major bleeding rates amo...
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
textIntroduction: Proton pump inhibitors (PPI) may impair the biotransformation of clopidogrel leadi...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
CONTEXT: Enoxaparin or the combination of glycoprotein IIb/IIIa inhibitor tirofiban with unfractiona...
ObjectivesWe sought to evaluate whether enoxaparin (ENOX) is superior to unfractionated heparin (UFH...